Trial Profile
A phase I trial to evaluate the bioequivalence between a capsule and tablet formulation of Gemcabene in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Gemcabene (Primary)
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia; Hypertension; Hypertriglyceridaemia; Non-alcoholic steatohepatitis; Osteoarthritis
- Focus Pharmacokinetics
- 20 Apr 2017 New trial record